[Institute for safe medication practices: ISMP's list of high-alert medications. Pridobljeno 19.11.2009 s spletne strani: http://www.ismp.org/Tools/highalertmedications.pdf]Search in Google Scholar
[Phillips J, Beam S, Brinker A, et al: Retrospective analysis of mortalities associated with medication errors. Am J Health Syst Pharm 2001; 58: 1835-1841.10.1093/ajhp/58.19.183511596700]Search in Google Scholar
[Sonc M. Standardi kakovosti za področje onkološke farmacevtske dejavnosti. Ljubljana: Lekarniška zbornica Slovenije, 2009.]Search in Google Scholar
[Department of Health: The NHS cancer plan. London, HMSO, No. 22293, 2001.]Search in Google Scholar
[Green E, Johnston M, Trudeau M, Schwartz L, Poirer S, Macartney G, Milliken D. Safe handling of parenteral cytotoxics: recommenations for Ontario. J Oncol Pract posted online ahead of print on August 20, 2009.10.1200/JOP.091014279067020856737]Search in Google Scholar
[North East London Cancer Network NHS: Guidelines on the safe prescribing, handling and administration of cytotoxic drugs. London, Department of Health Publications, 2005.]Search in Google Scholar
[American Society of Health System Pharmacists: ASHP guidelines on handling hazardous drugs. Am J Health Syst Pharm 2006; 63: 1172-1193.10.2146/ajhp050529]Search in Google Scholar
[Mort D, Lansdown M, Smith N, et al: For better, for worse? London, National Confidential Enquiry into Patient Outcome and Death, 2008.]Search in Google Scholar
[Knez L, Laaksonen R, Duggan C, et al: Evaluation of clinical interventions made by pharmacists in cancer services. Pharm J 2008; 280: 277-280.]Search in Google Scholar
[Goldspiel BR, DeChristoforo R, Daniels CE: A continuous-improvement approach for reducing the number of chemotherapy-related medication errors. Am J Health Syst Pharm 2000; 57: S4-9.10.1093/ajhp/57.suppl_4.S411148943]Search in Google Scholar
[Macintyre J, Dalrymple H, MacLean F, et al: Development of a system for reporting pharmaceutical care issues in cancer patients receiving chemotherapy. Pharm J 2003; 271: 266-267.]Search in Google Scholar
[Liekweg A, Westfeld M, Jaehde U: From oncology pharmacy to pharmaceutical care: new contributions to multidisciplinary cancer care. Support Care Cancer 2004; 12: 3-79.10.1007/s00520-003-0539-414530957]Search in Google Scholar
[Slama C, Jerome J, Jacquot C, et al: Prescription errors with cytotoxic drugs and inadequacy of existing classifications. Pharm World Sci 2005; 27: 339-343.10.1007/s11096-005-6034-x16228634]Search in Google Scholar
[Markert A, Thierry V, Kleber M, et al: Chemotherapy safety and severe adverse events in cancer patients: strategies to efficiently avoid chemotherapy errors in in- and outpatient treatment. Int J Cancer 2009; 124: 722-728.10.1002/ijc.2399118989899]Search in Google Scholar
[Bolnišnica Golnik KOPA. Pridobljeno 19.11.2009 s spletne strani: www.klinika-golnik.si]Search in Google Scholar
[Baza podatkov o zdravilih Republike Slovenije. Pridobljeno 4.12.2009 s spletne strani: www.zdravila.net]Search in Google Scholar
[European Medicines Agency: Human Medicines. Pridobljeno 4.12.2009 s spletne strani: www.emea.europa.eu]Search in Google Scholar
[Cancer Care Ontario: Cancer Drugs. Pridobljeno 4.12.2009 s spletne strani: http://www.cancercare.on.ca]Search in Google Scholar
[National Comprehensive Cancer Network: NCCN Chemotherapy Order Templates. Pridobljeno 4.12.2009 s spletne strani: http://www.nccn.org]Search in Google Scholar
[Kuhlmann MK, Burkhardt G, Köhler H: Insights into potential cellular mechanisms of cisplatin nephrotoxicity and their clinical application. Nephrol Dial Transplant 1997; 12: 2478-2480.10.1093/ndt/12.12.24789430835]Search in Google Scholar
[Roila F, Hesketh PJ, Herrstedt J; Antiemetic Subcommitte of the Multinational Association of Supportive Care in Cancer: Prevention of chemotherapy- and radiotherapy-indiced emesis: results of the 2004 Perugia Internetional Antiemetic Consensus Conference. Ann Oncol 2006; 17: 20-28.10.1093/annonc/mdj07816314401]Search in Google Scholar
[Floyd J, Mirza I, Sachs B, et al: Hepatotoxicity of chemotherapy. Semin Oncol 2006; 33: 50-67.10.1053/j.seminoncol.2005.11.00216473644]Search in Google Scholar
[Allan EL, Barker KN: Fundamentals of medication error research. Am J Hosp Pharm 1990; 47: 555-571.10.1093/ajhp/47.3.555]Search in Google Scholar
[Pajk B: Neželeni učinki sistemskega zdravljenja raka. Onkologija za prakso, 2007; 2: 131-138.]Search in Google Scholar
[Jaehde U, Liekwig A, Simos S, et al: Minimising treatment-associated risks in systemic cancer therapy. Pharm World Sci 2008; 30: 161-168.10.1007/s11096-007-9157-4225365217906939]Search in Google Scholar